Marleen Bouhuys, Paola Mian, & Patrick F. van Rheenen. (2023). Ustekinumab trough levels in children with Crohn's disease refractory to anti-tumor necrosis factor agents: A prospective case series of off-label use. Frontiers Media S.A..
Chicago Style (17th ed.) CitationMarleen Bouhuys, Paola Mian, and Patrick F. van Rheenen. Ustekinumab Trough Levels in Children with Crohn's Disease Refractory to Anti-tumor Necrosis Factor Agents: A Prospective Case Series of Off-label Use. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationMarleen Bouhuys, et al. Ustekinumab Trough Levels in Children with Crohn's Disease Refractory to Anti-tumor Necrosis Factor Agents: A Prospective Case Series of Off-label Use. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.